Noile-Immune Biotech Inc. 4893Short Interest
No institution currently reports a short position of 0.5% or more in Noile-Immune Biotech Inc. (4893). The last disclosure was on 2026-10-15 (Daiwa Securities Co. Ltd., 0.46%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
349 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2024-03-04 |
|---|---|
| Latest disclosure | 2026-10-15 (Daiwa Securities Co. Ltd., 0.46%) |
| Reporting institutions | 6 firms (349 reports) |
| Peak estimated short interest | 5.83% (2024-10-30, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Daiwa Securities Co. Ltd.
- Morgan Stanley MUFG Securities Co., Ltd.
- Nomura International plc
- GOLDMAN SACHS INTERNATIONAL
- UBS AG
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-04-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 215,500 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2025-02-27 | UBS AG | Position 212,100 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-06-12 | GOLDMAN SACHS INTERNATIONAL | Position 209,700 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-10-15 | Daiwa Securities Co. Ltd. | Position 200,300 shares | Ratio 0.46% | ▼0.10% | Below 0.5% |
| 2026-10-15 | Nomura International plc | Position 194,300 shares | Ratio 0.44% | ▼0.11% | Below 0.5% |
| 2026-10-14 | Okasan Securities Co., Ltd. | Position 150,000 shares | Ratio 0.34% | ▼0.23% | Below 0.5% |
Disclosure History 349 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-15 | Nomura International plc | Position 194,300 shares | Ratio 0.44% | ▼0.11% | Below 0.5% |
| 2026-10-15 | Daiwa Securities Co. Ltd. | Position 200,300 shares | Ratio 0.46% | ▼0.10% | Below 0.5% |
| 2026-10-14 | Okasan Securities Co., Ltd. | Position 150,000 shares | Ratio 0.34% | ▼0.23% | Below 0.5% |
| 2026-10-13 | Nomura International plc | Position 241,603 shares | Ratio 0.55% | ▼0.06% | — |
| 2026-10-09 | Daiwa Securities Co. Ltd. | Position 245,500 shares | Ratio 0.56% | ▼0.19% | — |
| 2026-10-09 | Okasan Securities Co., Ltd. | Position 250,000 shares | Ratio 0.57% | ▲0.11% | — |
| 2026-10-08 | Nomura International plc | Position 268,803 shares | Ratio 0.61% | ▲0.08% | — |
| 2026-10-07 | Nomura International plc | Position 232,903 shares | Ratio 0.53% | ▲0.10% | — |
| 2026-10-06 | Daiwa Securities Co. Ltd. | Position 325,700 shares | Ratio 0.75% | ▼0.08% | — |
| 2026-09-24 | Daiwa Securities Co. Ltd. | Position 363,700 shares | Ratio 0.83% | ▼0.16% | — |
| 2026-09-01 | Daiwa Securities Co. Ltd. | Position 429,700 shares | Ratio 0.99% | ▼0.09% | — |
| 2026-08-26 | Daiwa Securities Co. Ltd. | Position 470,000 shares | Ratio 1.08% | ▼0.08% | — |
| 2026-08-21 | Daiwa Securities Co. Ltd. | Position 506,700 shares | Ratio 1.16% | ▼0.08% | — |
| 2026-08-18 | Daiwa Securities Co. Ltd. | Position 542,000 shares | Ratio 1.24% | ▼0.14% | — |
| 2026-07-29 | Daiwa Securities Co. Ltd. | Position 600,100 shares | Ratio 1.38% | ▼0.09% | — |
| 2026-07-24 | Daiwa Securities Co. Ltd. | Position 641,500 shares | Ratio 1.47% | ▼0.10% | — |
| 2026-07-17 | Daiwa Securities Co. Ltd. | Position 682,900 shares | Ratio 1.57% | ▼0.12% | — |
| 2026-07-15 | Daiwa Securities Co. Ltd. | Position 735,600 shares | Ratio 1.69% | ▼0.09% | — |
| 2026-07-08 | Daiwa Securities Co. Ltd. | Position 773,100 shares | Ratio 1.78% | ▼0.11% | — |
| 2026-07-01 | Daiwa Securities Co. Ltd. | Position 824,500 shares | Ratio 1.89% | ▼0.07% | — |
| 2026-06-25 | Daiwa Securities Co. Ltd. | Position 853,300 shares | Ratio 1.96% | ▼0.12% | — |
| 2026-06-19 | Daiwa Securities Co. Ltd. | Position 905,200 shares | Ratio 2.08% | ▼0.08% | — |
| 2026-06-12 | GOLDMAN SACHS INTERNATIONAL | Position 209,700 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-06-05 | Daiwa Securities Co. Ltd. | Position 939,700 shares | Ratio 2.16% | ▼0.12% | — |
| 2026-06-01 | GOLDMAN SACHS INTERNATIONAL | Position 251,700 shares | Ratio 0.57% | ▲0.18% | — |
| 2026-05-29 | Daiwa Securities Co. Ltd. | Position 991,000 shares | Ratio 2.28% | ▼0.10% | — |
| 2026-05-20 | Daiwa Securities Co. Ltd. | Position 1,033,500 shares | Ratio 2.38% | ▼0.21% | — |
| 2026-05-19 | Daiwa Securities Co. Ltd. | Position 1,124,700 shares | Ratio 2.59% | ▼0.07% | — |
| 2026-05-18 | Daiwa Securities Co. Ltd. | Position 1,157,400 shares | Ratio 2.66% | ▼0.21% | — |
| 2026-05-12 | Daiwa Securities Co. Ltd. | Position 1,244,500 shares | Ratio 2.87% | ▼0.06% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| STELLA PHARMA CORPORATION4888 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |